natgillin/translations-raw huggingface dataset:
Some systemic adverse reactions, including headache (3.7%), influenza-like symptoms (1.1%), and myalgia (1.5%) were also reported.
Poročali so tudi o nekaterih sistemskih neželenih učinkih, med drugim tudi o glavobolu (3,7%), simptomih podobnih gripi (1,1%) in mialgiji (1,5%).
Some systemic adverse reactions, including headache, fatigue, were reported by imiquimod treated patients.
Pri bolnikih, zdravljenih z imikvimodom, so poročali o nekaterih sistemskih neželenih učinkih, vključno z glavobolom in utrujenostjo.
Some types of diuretics which may cause decrease in blood potassium level, such as furosemide, hydrochlorothiazide, indapamide (used to treat oedema, high blood pressure).
cisaprid (proti gastroezofagealnemu refluksu) nekatere vrste diuretikov, ki lahko povzročijo zmanjšanje vrednosti kalija v krvi, kot so furosemid, hidroklorotiazid, indapamid (ki se uporabljajo za zdravljenje edema, visokega krvnega tlaka).
Some types of vaccines (live vaccines) should not be given while using Stelara.
Zdravilo STELARA ne vsebuje konzervansov, zato neporabljenega zdravila, ki ostane brizgi, ne smete uporabiti.
Some types of vaccines (live vaccines) should not be given while using Stelara.
Živih cepiv se ne sme dajati sočasno z zdravilom STELARA (glejte poglavje 4.4).
Some undesirable effects have been reported since marketing of Aprovel.
Po prihodu zdravila Aprovel na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects have been reported since marketing of CoAprovel.
Po prihodu zdravila CoAprovel na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects have been reported since marketing of Irbesartan Hydrochlorothiazide Zentiva.
Po prihodu zdravila Irbesartan Hydrochlorothiazide Zentiva na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects have been reported since marketing of irbesartan.
Po prihodu zdravila Ifirmasta na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects have been reported since marketing of Karvezide.
Po prihodu zdravila Karvezide na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects have been reported since the marketing of the combination of irbesartan and hydrochlorothiazide.
Po prihodu zdravila, ki vsebuje kombinacijo irbesartana in hidroklorotiazida na tržišče so poročali še o nekaterih drugih neželenih učinkih.
Some undesirable effects mentioned under section 4.8 such as dizziness and vertigo may affect the ability to drive or use machines.
Na sposobnost vožnje in upravljanja s stroji lahko vplivajo določeni neželeni učinki, ki so navedeni v poglavju 4.8, na primer omotica ali vrtoglavica.
Some undesirable effects mentioned under section 4.8 “Undesirable effects” may affect the ability to drive or use machines.
Na sposobnost vožnje in upravljanja s stroji lahko vplivajo določeni neželeni učinki, ki so navedeni v poglavju 4.8 ”Neželeni učinki”.
Some vaccines should not be given while receiving Trudexa.
Med zdravljenjem s Trudexo se ne sme uporabljati nekaterih cepiv.
Some very common (i.e. in more than 10 % of dogs) adverse reactions associated with Palladia tablets are weight loss, diarrhoea, neutropenia (low number of white blood cells), blood in faeces/, hemorrhagic diarrhoea/gastrointestinal bleeding, anorexia, lethargy, vomiting; lameness / musculoskeletal disorder, dehydration, dermatitis, pruritus (skin irritation/scratching); increased alanine aminotransferase, thrombocytopenia, decreased albumin, decreased haematocrit.
Nekateri zelo pogosti (pri več kot 10% psov) neželeni učinki povezani s Palladia tabletami so izguba teže, diareja, neutropenija (nizko število belih krvnih celic), kri v iztrebkih, hemoragična diareja/gastrointestinalne krvavitve, anoreksija, letargičnost, bruhanje, šepanje/mišično skeletne motnje, dehidracija, dermatitis, srbenje (vnetje kože, praskanje); povečana alanin aminotransferaza, trombocitopenija, znižan albumin in znižan hematokrit.
Some very common and common side effects of MEPACT treatment (such as dizziness, vertigo, fatigue and blurred vision) may affect your ability to drive and use machines.
Nekateri zelo pogosti in pogosti neželeni učinki zdravljenja z zdravilom MEPACT (kot so omotica, vrtoglavica, utrujenost in zamegljen vid) lahko vplivajo na sposobnost vožnje in upravljanja s stroji.
Some white foam may remain in the vial this is normal.
V viali lahko ostane nekaj bele pene - to je normalno.
Some white foam may remain in the vial – this is normal.
V viali lahko ostane nekaj bele pene – to je normalno.
Some women being treated for rheumatoid arthritis with Inflectra have developed cervical cancer.
Pri nekaterih ženskah z revmatoidnim artritisom, ki so se zdravile z zdravilom Inflectra, se je pojavil rak materničnega vratu.
Some women being treated for rheumatoid arthritis with infliximab have developed cervical cancer.
Pri nekaterih ženskah z revmatoidnim artritisom, ki so se zdravile z infliksimabom, se je pojavil rak materničnega vratu.
Some women being treated for rheumatoid arthritis with Remicade have developed cervical cancer.
Pri nekaterih ženskah z revmatoidnim artritisom, ki so se zdravile z zdravilom Remicade, se je pojavil rak materničnega vratu.
Some women being treated for rheumatoid arthritis with Remsima have developed cervical cancer.
Pri nekaterih ženskah z revmatoidnim artritisom, ki so se zdravile z zdravilom Remsima, se je pojavil rak materničnega vratu.
Sometimes patches can stick to the inside of the sachet – be careful not to accidentally remove the clear covering as you remove the patch
Včasih se obliž prilepi na notranjo stran blazinice - pazite, da ponesreči ne odstranite prozorne plasti, ko obliž vzamete ven.
Sometimes people who have been infected do not look or feel ill.
Okuženi posamezniki se včasih sploh ne počutijo ali izgledajo bolni.
Sometimes you may need to stop taking your medicine for a short time.
Jemanje zdravila boste mogoče morali za krajše obdobje prekiniti.
Sometimes you may need to stop taking your medicine for a short time.
Včasih boste morda morali za kratek čas prenehati jemati zdravilo.
Sometimes, depending on where this happens, you may get an unusual discharge at that place.
Včasih se vam lahko – odvisno od tega, kje se to zgodi – pojavi nenavaden izcedek na tistem mestu.
Somnol ence
zaspanost
Somnolenc e
omnolenca
Somnolence
Diskinezija
Somnolence
omnolenca
Somnolence
omotica
somnolence
zaspanost
Somnolence
Zaspanost (10,7 %)
Somnolence
zaspanost,
Somnolence and episodes of sudden sleep onset
Somnolenca in epizode nenadnega nastopa spanca
Somnolence Confusion Hallucinations1 Psychotic reactions2
zaspanost zmedenost halucinacije1 psihotične reakcije2
Somnolence Headache
omnolenca glavobol
Somnolence Migraine
omnolenca migrena
Somnolence Paraesthesia and dysaesthesia
zaspanost parestezija in disestezije
Somnolence Paraesthesia Ataxia* Dystonia* Hyperreflexia*
Somnolenca Parestezija Ataksija* Distonija* Hiperrefleksija
Somnolence Tremor Syncope Seizures
epileptični napadi
Somnolence* Headache Dizziness*
zaspanost* glavobol omotica
Somnolence,
zaspanost,
Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with Keppra overdoses.
Pri prevelikem odmerjanju zdravila Keppra so opažali somnolenco, agitiranost, agresivnost, zmanjšano stopnjo zavesti, depresijo dihanja in komo.
Somnolence, agitation, aggression, depressed level of consciousness, respiratory depression and coma were observed with Matever overdoses.
Pri prevelikem odmerjanju zdravila Matever so opažali somnolenco, agitiranost, agresivnost, zmanjšano stopnjo zavesti, depresijo dihanja in komo.
Somnolence, convulsions
somnolenca, krči
Somnolence, dizziness
omnolenca, omotica
Somnolence, dizziness, headache
omnolenca, omotica, glavobol
Somnolence, dizziness, palpitations, abdominal pain, nausea, ankle swelling.
omnolenca, omotica, palpitacije, bolečine v trebuhu, navzea, otekanje gležnjev
Somnolence, dizziness, paraesthesia
zaspanost, omotica, parestezije
Somnolence, dizziness, paraesthesia and blurred vision have been reported with the use of Febuxostat.
Po uporabi febuksostata so poročali o neželenih učinkih, kot so zaspanost, omotica, parestezija in zamegljen vid.
Somnolence, dizziness, paresthesia
somnolenca, omotica, parestezija
Somnolence, headache
omnolenca, glavobol
Somnolence, headache (especially at the beginning of treatment)
zaspanost, glavobol (zlasti na začetku zdravljenja)
Somnolence, Hypoaesthesia
zaspanost, hipestezija
Somnolence, insomnia, paraesthesia, hypersomnia, peripheral sensory neuropathy
zaspanost, nespečnost, parastezije, hipersomnija, periferna senzorna nevropatija
somnolence, migraine, headache, paraesthesia
somnolenca, migrena, glavobol, parestezija
somnolence, taste perversion
somnolenca, motnje okusa
somnolence, taste perversion
zaspanost, motnje okusa
Somnolence, tremor, dysaesthesia
omnolenca, tremor, disestezija
Somnolence/sedation, hypotension, bradycardia and syncope
Somnolenca /sedacija, hipotenzija, bradikardija in sinkopa
Somnolence2
zaspanost2
Somnolence; tremor
somnolenca, tremor
Somnolenceam, headache (especially at the beginning of treatment)am
zaspanostam, glavobol (zlasti na začetku zdravljenja)am
Sonata 10 mg hard capsules
Sonata 10 mg trde kapsule
Sonata 5 mg hard capsules
Sonata 5 mg trde kapsule
Sonata 5 mg hard capsules, which contain a light blue powder, have a light brown cap and white body, with gold imprint “5 mg”.
Sonata 5 mg trde kapsule, ki vsebujejo svetlo moder prašek, imajo svetlo rjav pokrovček in belo telo z zlatim odtisom »5 mg«.
Sonata has been designed, so that if the contents of the capsule are dissolved in liquid, the liquid will change colour and become cloudy.
Zdravilo Sonata je zasnovano tako, da tekočina, v kateri se vsebina kapsule raztopi, spremeni barvo in postane motna.
Sonata has major influence on the ability to drive and use machines.
Zdravilo Sonata ima velik vpliv na sposobnost vožnje in upravljanja s stroji.
Sonata is contraindicated in children and adolescents under 18 years of age (see section 4.3).
Uporaba zdravila Sonata je kontraindicirana pri otrocih in mladostnikih, mlajših od 18 let (glejte poglavje 4.3).
Sonata’s efficacy has been demonstrated in both sleep laboratory studies using objective polysomnography (PSG) measures of sleep and in outpatient studies using patient questionnaires to assess sleep.
Učinkovitost zdravila Sonata je bila dokazana tako v študijah v spalnih laboratorijih z uporabo meritev spanja pri objektivni polisomnografiji (PSG) in v ambulantnih študijah z vprašalniki, v katerih so bolniki ocenjevali svoje spanje.
Sonidegib binding to Smo will inhibit Hh signalling and consequently block signal transduction.
Vezava sonidegiba na protein Smo zavira signaliziranje Hh in tako blokira prenos signala.
Sonidegib is a competitive inhibitor of CYP2B6 and CYP2C9 in vitro, potentially increasing the concentrations of substances metabolised by these enzymes.
Sonidegib je in vitro kompetitivni zaviralec CYP2B6 oziroma CYP2C9 in bi lahko zvišal koncentracije tistih snovi, ki se presnavljajo z navedenimi encimi.
Sonidegib is also a breast cancer resistance protein (BCRP) inhibitor (IC50 ~1.5µM).
Sonidegib je tudi zaviralec proteina rezistence pri raku dojke (angl. breast cancer resistance protein, BCRP) s srednjo inhibitorno koncentracijo (IC50) približno 1,5 µmol/l.
Sonidegib undergoes metabolism primarily by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 can increase or decrease sonidegib concentrations significantly.
Sonidegib se primarno presnavlja s CYP3A4, zato sočasno odmerjanje močnih zaviralcev ali induktorjev CYP3A4 lahko bistveno zviša oziroma zniža koncentracijo sonidegiba.
SonoVue 8 microlitres / ml powder and solvent for dispersion for injection
SonoVue 8 mikrolitrov/ml prašek in vehikel za disperzijo za injiciranje
SonoVue 8 microlitres/ml powder and solvent for dispersion for injection sulphur hexafluoride
SonoVue 8 mikrolitrov/ml prašek in vehikel za disperzijo za injiciranje žveplov heksafluorid
SonoVue 8 microlitres/ml powder for dispersion for injection
SonoVue 8 mikrolitrov/ml prašek in vehikel za disperzijo za injiciranje
SonoVue can be used in Doppler tests for large blood vessels, such as those in the head, those leading to the head or the main vein to the liver, or for smaller blood vessels such as those in lesions (areas of disease) in the breast or liver.
Zdravilo SonoVue se lahko uporablja pri Dopplerjevih preiskavah velikih krvnih žil, kot so žile v glavi, žile, ki potekajo do glave, ali glavna vena do jeter, ali manjših krvnih žil, na primer pri lezijah (območjih bolezni) v prsih ali jetrih.
SonoVue dispersion should be administered to you within six hours of its preparation.
Disperzijo zdravila SonoVue je treba porabiti v roku šestih ur po pripravi.
SonoVue has been studied in a total of 895 patients in six main studies.
Zdravilo SonoVue so proučili v šestih glavnih študijah, v katere je bilo vključenih skupno 895 bolnikov.
SonoVue improves display of the vascularity of liver and breast lesions during Doppler sonography, leading to more specific lesion characterisation.
Zdravilo SonoVue izboljša prikaz vaskularnosti lezij v jetrih in dojkah pri dopplerski sonografiji, kar daje bolj specifične podatke o lezijah.
SonoVue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries by improving the Doppler signal to noise ratio.
Zdravilo SonoVue poveča natančnost pri zaznavanju ali izključitvi anomalij v cerebralnih arterijah in v ekstrakranialnih karotidnih arterijah ali perifernih arterijah z izboljšanjem dopplerjevega razmerja med signalom in šumom.
SonoVue increases the quality of the Doppler flow image and the duration of clinically-useful signal enhancement in portal vein assessment.
Zdravilo SonoVue poveča kakovost dopplerskega posnetka pretoka in trajanje klinično uporabnega pojačanega signala za preiskavo portalne vene.
SonoVue is a contrast agent that helps to obtain clearer ultrasound pictures of your heart or your blood vessels and/or tissues of the liver and breast.
SonoVue je kontrastno sredstvo, ki pomaga pridobiti jasnejšo ultrazvočno sliko srca ali ožilja in/ali tkiva jeter in prsi.
SonoVue is a medicine that contains the active substance sulphur hexafluoride (a gas).
SonoVue je zdravilo, ki vsebuje zdravilno učinkovino žveplov heksafluorid (plin).
SonoVue is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.
Zdravilo SonoVue je transpulmonalno ehokardiografsko kontrastno sredstvo, ki se uporablja pri bolnikih s sumom na ali z dokazanim kardiovaskularnim obolenjem, da zagotovi opacifikacijo srčnih votlin in izboljša razmejitev konture endokardija levega ventrikla.
SonoVue is contraindicated in patients known to have right-to-left shunts, severe pulmonary hypertension (pulmonary artery pressure >90 mmHg), uncontrolled systemic hypertension, and in patients with adult respiratory distress syndrome.
Zdravilo SonoVue je kontraindicirano pri bolnikih z desno-levim šantom, akutnim endokarditisom, umetnimi srčnimi zaklopkami, s hudo pulmonalno hipertenzijo (pulmonalni arterijski tlak > 90 mm Hg), nenadzorovano hipertenzijo in pri odraslih bolnikih z respiratornim distresnim sindromom.
SonoVue is for diagnostic use only.
Zdravilo SonoVue se uporablja samo v diagnostične namene.
SonoVue is for use with ultrasound imaging to enhance the echogenicity of the blood, which results in an improved signal to noise ratio.
Zdravilo SonoVue uporabljamo pri ultrazvočnih preiskavah, kjer poveča ehogenost krvi, kar se pokaže z izboljšanim razmerjem med signalom in šumom.
SonoVue is not suitable for use in ventilated patients, and those with unstable neurological diseases.
Zdravilo SonoVue ni primeren za bolnike, ki so umetno ventilirani in za bolnike z nestabilnimi nevrološkimi boleznimi.
SonoVue is used in tests that measure how ultrasound travels within the body because it improves the ability of the blood to create an echo.
Uporablja se pri preiskavah, s katerimi se ugotavlja, kako ultrazvok potuje po telesu, saj poveča sposobnost krvi, da izzove odboj.
SonoVue must be prepared before use by injecting through the septum 5 ml of sodium chloride
Zdravilo SonoVue morate pred uporabo pripraviti.
SonoVue must not be used in patients known to have right-to-left shunts (abnormal movement of blood within the heart), severe pulmonary hypertension (high blood pressure in the pulmonary artery, the blood vessel that leads from the heart to the lungs), uncontrolled hypertension (high blood pressure) or adult respiratory distress syndrome (severe fluid build-up in both lungs).
Zdravila SonoVue ne smejo uporabljati bolniki z desno-levim šantom (nenormalnim pretokom krvi v srcu), hudo pljučno hipertenzijo (visokim krvnim tlakom v pljučni arteriji, tj. žili, ki vodi od srca do pljuč), nenadzorovano hipertenzijo (visokim krvnim tlakom) ali sindromom dihalne stiske pri odraslih (obilnega kopičenja tekočine v obeh pljučnih krilih).
SonoVue should be administered immediately after drawing into the syringe by injection into a peripheral vein.
Zdravilo SonoVue moramo dati bolniku v periferno veno takoj, ko potegnemo disperzijo v brizgo.
SonoVue should be administered immediately by injection into a peripheral vein.
Zdravilo SonoVue morate aplicirati takoj z injiciranjem v periferno veno.
Sonovue should not be used in combination with dobutamine in patients with conditions suggesting cardiovascular instability where dobutamine is contraindicated.
Zdravilo SonoVue se ne sme uporabljati v kombinaciji z dobutaminom pri bolnikih, ki kažejo na kardiovaskularno nestabilnost, kjer je dobutamin kontraindiciran.
SonoVue should not be used in patients under 18 years of age as it has not been studied in these groups.
Zdravila SonoVue se ne sme uporabljati pri bolnikih, mlajših od 18 let, saj ni bilo raziskano pri teh skupinah.
Sonovue should only be administered to such patients after careful risk/benefit assessment and a closely monitoring of vital signs should be performed during and after administration.
Pri teh bolnikih se sme zdravilo SonoVue lahko uporabljati le po temeljiti oceni tveganja/koristi in ob pozornem spremljanju vitalnih znakov med in po uporabi.
SonoVue should only be used by doctors who have experience in diagnostic ultrasound imaging.
Zdravilo SonoVue smejo uporabljati le zdravniki, ki imajo izkušnje z diagnostičnim ultrazvočnim slikanjem.
SonoVue sulphur hexafluoride microbubbles 8 microlitres/ml Powder and solvent for dispersion for injection
SonoVue, žveplov heksafluorid v obliki mikromehurčkov 8 mikrolitrov/ml prašek in vehikel za disperzijo za injiciranje
Sorbitan laurate
orbitan lavrat
Sorbitan mono-oleate Polysorbate 80 Sodium chloride Potassium chloride
orbitan mono-oleat polisorbat 80 natrijev klorid kalijev klorid
Sorbitan oleate (E 494), Potassium dihydrogen phosphate (E 340), Disodium hydrogen phosphate (E 339) and Potassium chloride (E 508) are approved as additives in foodstuffs for human consumption and therefore covered by Annex II of Council Regulation (EEC) No.
Sorbitan oleat (E 494), kalijev dihidrogenfosfat (E 340), natrijev dihidrogenfosfat (E 339) in kalijev klorid (E 508) so odobreni prehrambeni dodatki, zato jih ureja Dodatek II Uredbe Sveta (EGS) št.
Sorbitan sesquioleate Polysorbate 80 Thiomersal
Sorbitan seskvioleat Polisorbat 80 Tiomersal
Sorbitol (E420) liquid (crystallising) Microcrystalline cellulose (E460) Carmellose sodium (E466) Poloxamer 188
sorbitol (E420) tekoči (kristalizirajoči) mikrokristalna celuloza (E460) natrijev karmelozat (E466) poloksamer 188
Sorbitol liquid non-crystallising
orbitol tekoči, nekristalizirajoči
Sorbitol Polysorbate 20 Water for injections
natrijev dihidrogenfosfat monohidrat argininijev klorid sorbitol polisorbat 20 voda za injekcije
Sorbitol Talc
Sorbitol Smukec
sorbitol, propylene glycol, sucralose E 955,
sorbitol, propilenglikol, sukraloza E 955,
Sorbitol, sodium phosphate, potassium phosphate, sucrose, hydrolysed gelatin medium 199 with Hanks’ salts, MEM, monosodium L-glutamate, neomycin, phenol red, sodium bicarbonate, hydrochloric acid , sodium hydroxide and water for injections.
sorbitol, natrijev fosfat, kalijev fosfat, saharoza, hidrolizirana želatina, medij 199 s Hanksovimi solmi, MEM, natrijev L-glutamat, neomicin, fenol rdeče, natrijev hidrogenkarbonat, klorovodikova kislina, natrijev hidroksid in voda za injekcije
Sorbitol, sodium phosphate, potassium phosphate, sucrose, hydrolysed gelatine, medium 199 with Hanks’ salts, MEM, monosodium L-glutamate, neomycin, phenol red, sodium bicarbonate, hydrochloric acid , sodium hydroxide and water for injections.
sorbitol, natrijev fosfat, kalijev fosfat, saharoza, hidrolizirana želatina, medij 199 s Hanksovimi solmi, MEM, natrijev L-glutamat, neomicin, fenol rdeče, natrijev hidrogenkarbonat, klorovodikova kislina, natrijev hidroksid in voda za injekcije
Sorbitol: If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Sorbitol: Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred uporabo tega zdravila posvetujte z zdravnikom.
Sorbitol; Polysorbate 20; Water for injections
natrijev dihidrogenfosfat monohidrat, argininijev klorid, sorbitol, polisorbat 20, voda za injekcije.
Sore (open skin infection) on your skin.
rane (odprte kožne okužbe) na koži
Sore inflamed mouth, dry mouth, difficulty swallowing
vneta usta, suha usta, težave s požiranjem;
Sore mouth
vnetje v ustih,
Sore mouth (stomatitis)
vnetje v ustih (stomatitis),
Sore mouth (stomatitis).
vnetje ust (stomatitis)
Sore mouth or lip, throat pain
vnetje ust ali ustnic, bolečina v žrelu
Sore mouth or lip, throat pain
vnetje ust ali ustnic, bolečina v žrelu, razjede v ustih
Sore mouth or mouth ulcers, inflammation of mucous membranes
pekoča usta ali razjede v ustih, vnetje sluznic
Sore mouth or mouth ulcers, inflammation of mucous membranes
vnetje ali razjede ustne sluznice, vnetje sluznic
Sore nose and throat.
vnetje nosu in žrela
Sore or runny nose or sinuses (sinusitis)..
vnetje nosu, izcedek iz nosu ali sinuzitis
Sore throat
boleče grlo ali žrelo
Sore throat
vnetje žrela
Sore throat
vnetje žrela,
Sore throat
vneto grlo
Sore throat
vneto grlo,
Sore throat (pharyngitis)
vnetje žrela (faringitis)
Sore throat and runny nose (nasopharyngitis)
vnetje žrela oziroma grla in izcedek iz nosu (nazofaringitis)
Sore throat and runny or blocked up nose
vnetje žrela in zamašen nos ali nosni izcedek
Sore throat or nose and throat irritation
vnetje grla ali nosa in draženje grla
Sore throat, Dysaesthesia pharynx
boleče žrelo, disestezija
Sore throat, Dysaesthesia pharynx
boleče žrelo, disestezija v žrelu
Sore throat, Dysaesthesia pharynx
Zelo pogosti
Sore throat, increase in mucus that is coughed up, difficulty in breathing, disorder of the voice, cough, yawning
vnetje žrela, povečano izločanje sluzi, ki jo izkašljate, težave z dihanjem, motnje glasu, kašelj, zehanje;
Sore throat, red, sore or runny nose, flu-like symptoms and fever
vnetje žrela, pordel nos, vnetje nosne sluznice ali izcedek iz nosu, gripi podobni simptomi in zvišana telesna temperatura
Sore throat, reduced sense of taste
boleče grlo, zmanjšan čut okusa,
Sore throat, runny nose, blocked nose, sneezing, feeling of pressure or pain in the cheeks and/or forehead with or without fever (nasopharyngitis, pharyngitis, rhinitis, sinusitis).
vnetje žrela, izcedek iz nosu, zamašen nos, kihanje, občutek pritiska ali bolečine v predelu lic in/ali čela z zvišano telesno temperaturo ali brez nje (nazofaringitis, vnetje žrela, nahod, sinusitis)
Sore throat, sore or runny nose, flu-like symptoms, throat pain
vnetje v žrelu, boleč nos ali nahod, gripi podobni simptomi, bolečine v žrelu
Sore throat.
vnetje grla
Sore throat.
Vneto žrelo.
Soreness (touch is painful) and swelling of the palms of hands and soles of feet followed by the hands and feet becoming scaly
občutljivost (dotik je boleč) in otekanje dlani in podplatov, kateremu sledi luščenje rok in stopal